Variables† | Estimate | SE | OR (95% CI) | p |
Complication versus no complication | ||||
Waist circumference | 0.0277 | 0.0146 | 1.03 (1.00 to 1.06) | 0.058 |
Cholesterol total | −0.4024 | 0.1716 | 0.67 (0.48 to 0.94) | 0.019* |
eGFR | −0.0354 | 0.0138 | 0.97 (0.94 to 0.99) | 0.010* |
Duration of type 2 diabetes | 0.5047 | 0.1707 | 1.66 (1.19 to 2.31) | 0.003* |
Coronary artery disease (CAD) versus no CAD | ||||
Creatinine | −0.0047 | 0.0027 | 1.00 (0.99 to 1.00) | 0.085 |
eGFR | −0.0210 | 0.0081 | 0.98 (0.96 to 0.99) | 0.010* |
Smoking | 0.6839 | 0.2702 | 1.98 (1.17 to 3.38) | 0.011* |
Duration of type 2 diabetes | 0.2240 | 0.0855 | 1.25 (1.06 to 1.48) | 0.009* |
Retinopathy versus no retinopathy | ||||
Age | −0.0586 | 0.0160 | 0.94 (0.91 to 0.97) | 0.00025* |
BMI | 0.0620 | 0.0309 | 1.06 (1.00 to 1.13) | 0.045 |
Waist circumference | −0.0574 | 0.0153 | 0.94 (0.91 to 0.97) | 0.00018* |
HbA1c | −0.1669 | 0.0886 | 0.85 (0.71 to 1.00) | 0.0598 |
Cholesterol-total | 1.2527 | 0.3973 | 3.50 (1.64 to 7.80) | 0.0016* |
Triglycerides | −0.5821 | 0.2113 | 0.56 (0.37 to 0.84) | 0.0059* |
LDL-cholesterol | −1.2845 | 0.4356 | 0.28 (0.12 to 0.64) | 0.0032* |
eGFR | 0.0144 | 0.0084 | 1.01 (1.00 to 1.03) | 0.085 |
Neuropathy versus no neuropathy | ||||
Urea | 0.1335 | 0.0589 | 1.14 (1.02 to 1.29) | 0.023 |
†Only significant and suggestive associations are shown.
BMI, body mass index; eGFR, estimated glomerular filtration rate.